Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Read more about Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma Read more about Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises Read more about Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
Treatment of Acute Lymphoblastic Leukemia in Children Read more about Treatment of Acute Lymphoblastic Leukemia in Children
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy Read more about Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease Read more about Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma Read more about A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma Read more about Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Read more about Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma